Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Post-SPAC Black Rifle Coffee Stock Needs Some Time to Percolate

By Alex Sirois, InvestorPlace Contributor

Black Rifle Coffee Company's strong fanbase likes both the company's purpose and product, though, admittedly, BRCC stock may not be everyone's cup of tea.

The Market Has Spoken, and It Says Ethereum Is Valuable

By Alex Sirois, InvestorPlace Contributor

Technical analysis is an imperfect science, but there aren't many other good indicators for an asset like Ethereum, the No. 2 crypto.

Nio Stock Should Trade Sideways as its Earnings Period Approaches

By Alex Sirois, InvestorPlace Contributor

NIO stock remains a strong bet for the long-term, but that doesn't matter in the face of the current economic environment.

Sundial Growers Continues to Have Little in the Way of Good News

By Alex Sirois, InvestorPlace Contributor

SNDL stock is not a star and never has been. The cannabis firm's continued troubles are now cropping up in the form of Nasdaq warnings.

Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not

By Alex Sirois, InvestorPlace Contributor

NVAX stock has been derided as a ran in the vaccine race, avoid that narrative and remain optimistic because the best is ahead for Novavax.

Load More